^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

HLA-DQB1*05:01

i
Entrez ID:
Related biomarkers:
2ms
Host and Viral Factors Influencing Chronic Hepatitis B Infection Across Three Generations in a Family. (PubMed, Curr Microbiol)
Analysis of viral sequences, HLA-DQB1 variations, cytokine polymorphisms, and genetic relationships within the phylogenetic tree revealed that 40% of CHB patients from three-generation families were infected by a shared source of transmission, as indicated by the presence of the same HBV genotype. This study underscores the complex interplay of host and viral factors that influence hepatitis B infection outcomes and suggests potential familial transmission pathways.
Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • HLA-DQB1 (Major Histocompatibility Complex, Class II, DQ Beta 1) • IL10 (Interleukin 10) • IL18 (Interleukin 18)
|
HLA-DQB1*05:01
3years
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1). (PubMed, Cancer Sci)
Eighty-two transplant-ineligible patients with newly diagnosed MM enrolled in a phase II study (JCOG1105) comparing two less intensive melphalan, prednisolone, plus Btz (MPB) regimens were subjected to HLA typing. CR was achieved in patients carrying HLA-DQB1*03:02, -DQB1*05:01, and -DRB1*01:01-class II alleles. HLA genotyping may help predict Btz-induced toxicity and treatment efficacy in patients with MM, although this needs further validation.
Clinical • Journal
|
HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1) • HLA-DQB1 (Major Histocompatibility Complex, Class II, DQ Beta 1)
|
HLA-DQB1*03:02 • HLA-DQB1*05:01 • HLA-DRB1*01:01
|
bortezomib • melphalan